头孢比普对12种革兰氏阳性菌的抗生素后效应
Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms.
作者信息
Pankuch G A, Appelbaum P C
机构信息
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.
出版信息
Antimicrob Agents Chemother. 2006 Nov;50(11):3956-8. doi: 10.1128/AAC.00724-06.
Abstract
The in vitro postantibiotic effects (PAEs), postantibiotic sub-MIC effects (PA-SMEs), and sub-MIC effects of ceftobiprole were determined for 12 gram-positive organisms. Pneumococcal, staphylococcal, and enterococcal PAEs were 1.4 to 3.1 h, 0 to 1.8 h, and 0 to 0.9 h, respectively. The PA-SMEs (0.4 times the MIC) for pneumococci, staphylococci, and enterococci were 4.8 to >10.3 h, 1.5 to 9.6 h, and 3.8 to >10.7 h, respectively.
摘要
对12种革兰氏阳性菌测定了头孢托罗的体外抗生素后效应（PAEs）、亚抑菌浓度抗生素后效应（PA-SMEs）及亚抑菌浓度效应。肺炎球菌、葡萄球菌和肠球菌的PAEs分别为1.4至3.1小时、0至1.8小时和0至0.9小时。肺炎球菌、葡萄球菌和肠球菌的PA-SMEs（0.4倍MIC）分别为4.8至>10.3小时、1.5至9.6小时和3.8至>10.7小时。
相似文献
1
Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms.头孢比普对12种革兰氏阳性菌的抗生素后效应
Antimicrob Agents Chemother. 2006 Nov;50(11):3956-8. doi: 10.1128/AAC.00724-06.
2
Postantibiotic effect of DX-619 against 16 gram-positive organisms.DX-619对16种革兰氏阳性菌的抗生素后效应。
Antimicrob Agents Chemother. 2005 Sep;49(9):3963-5. doi: 10.1128/AAC.49.9.3963-3965.2005.
3
Postantibiotic effect of ceftaroline against gram-positive organisms.头孢洛林对革兰氏阳性菌的抗生素后效应。
Antimicrob Agents Chemother. 2009 Oct;53(10):4537-9. doi: 10.1128/AAC.00785-09.
4
In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.新型β-内酰胺类药物头孢比普对耐甲氧西林金黄色葡萄球菌的体外活性研究
Clin Microbiol Infect. 2007 Jun;13 Suppl 2:17-24. doi: 10.1111/j.1469-0691.2007.01722.x.
5
In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.头孢托罗在体外对常见需氧和兼性革兰阳性及革兰阴性细菌病原体的活性：CANWARD 2007-2009 研究结果。
Diagn Microbiol Infect Dis. 2011 Mar;69(3):348-55. doi: 10.1016/j.diagmicrobio.2010.10.032.
6
Postantibiotic effect of tigecycline against 14 gram-positive organisms.替加环素对14种革兰氏阳性菌的抗生素后效应。
Antimicrob Agents Chemother. 2009 Feb;53(2):782-4. doi: 10.1128/AAC.01122-08. Epub 2008 Dec 8.
7
Postantibiotic effects of telavancin against 16 gram-positive organisms.替考拉宁对16种革兰氏阳性菌的抗生素后效应。
Antimicrob Agents Chemother. 2009 Mar;53(3):1275-7. doi: 10.1128/AAC.01244-08. Epub 2009 Jan 5.
8
Postantibiotic effects of garenoxacin (BMS-284756) against 12 gram-positive or -negative organisms.加替沙星（BMS - 284756）对12种革兰氏阳性或阴性菌的抗生素后效应
Antimicrob Agents Chemother. 2003 Mar;47(3):1140-2. doi: 10.1128/AAC.47.3.1140-1142.2003.
9
Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.利奈唑胺对革兰氏阳性菌的抗生素后生长抑制作用。
J Antimicrob Chemother. 2001 Jun;47(6):879-83. doi: 10.1093/jac/47.6.879.
10
Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.左氧氟沙星和环丙沙星对金黄色葡萄球菌和肺炎链球菌的抗生素后效应及抗生素后亚抑菌浓度效应比较
Antimicrob Agents Chemother. 1997 May;41(5):950-5. doi: 10.1128/AAC.41.5.950.
引用本文的文献
1
Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse®) in .万古霉素与双硫仑（戒酒硫®）在……中的抗菌药效学
Front Microbiol. 2023 Jan 6;13:1092257. doi: 10.3389/fmicb.2022.1092257. eCollection 2022.
2
Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.DNA 拓扑异构酶 I 抑制剂对肺炎链球菌的抗菌活性与氟喹诺酮类药物的比较。
PLoS One. 2020 Nov 3;15(11):e0241780. doi: 10.1371/journal.pone.0241780. eCollection 2020.
3
Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.抗细菌药物后效应和亚抑菌浓度效应增强依替巴肽（Lysin CF-301）对金黄色葡萄球菌的抗菌活性。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02616-18. Print 2019 Jun.
4
Ceftobiprole for the treatment of pneumonia: a European perspective.头孢比普用于治疗肺炎：欧洲视角
Drug Des Devel Ther. 2015 Aug 18;9:4565-72. doi: 10.2147/DDDT.S56616. eCollection 2015.
5
Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.头孢托罗匹酯：在治疗医院获得性或社区获得性肺炎患者中的应用评价。
Drugs. 2014 Sep;74(13):1523-42. doi: 10.1007/s40265-014-0273-x.
6
Postantibiotic effects and postantibiotic sub-MIC effects of tilmicosin, erythromycin and tiamulin on erythromycin-resistant Streptococcus suis.替米考星、红霉素和泰妙菌素对耐红霉素猪链球菌的抗生素后效应和抗生素后亚 MIC 效应。
Braz J Microbiol. 2009 Oct;40(4):980-7. doi: 10.1590/S1517-838220090004000033. Epub 2009 Dec 1.
7
Emerging agents to combat complicated and resistant infections: focus on ceftobiprole.用于治疗复杂和耐药感染的新型药物：重点关注头孢洛林。
Infect Drug Resist. 2010;3:5-14. doi: 10.2147/idr.s3681. Epub 2010 Apr 22.
8
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole.耐药与复杂性皮肤及皮肤结构感染的管理：头孢托罗的作用。
Ther Clin Risk Manag. 2010 Oct 5;6:485-95. doi: 10.2147/TCRM.S5823.
9
Postantibiotic effect of ceftaroline against gram-positive organisms.头孢洛林对革兰氏阳性菌的抗生素后效应。
Antimicrob Agents Chemother. 2009 Oct;53(10):4537-9. doi: 10.1128/AAC.00785-09.
10
Postantibiotic effects of telavancin against 16 gram-positive organisms.替考拉宁对16种革兰氏阳性菌的抗生素后效应。
Antimicrob Agents Chemother. 2009 Mar;53(3):1275-7. doi: 10.1128/AAC.01244-08. Epub 2009 Jan 5.
本文引用的文献
1
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.新型广谱头孢菌素头孢比普的抗葡萄球菌活性
Antimicrob Agents Chemother. 2005 Oct;49(10):4210-9. doi: 10.1128/AAC.49.10.4210-4219.2005.
2
Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.新型广谱头孢菌素头孢比普的抗肺炎球菌活性
Antimicrob Agents Chemother. 2005 May;49(5):1932-42. doi: 10.1128/AAC.49.5.1932-1942.2005.
3
Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.新型广谱头孢菌素（BAL5788）在健康志愿者中的单剂量药代动力学及安全性
Antimicrob Agents Chemother. 2004 Jul;48(7):2570-5. doi: 10.1128/AAC.48.7.2570-2575.2004.
4
Use of the t > MIC to choose between different dosing regimens of beta-lactam antibiotics.使用t>MIC来在β-内酰胺类抗生素的不同给药方案之间进行选择。
J Antimicrob Chemother. 2001 Apr;47(4):500-1. doi: 10.1093/jac/47.4.500.
5
In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.Ro 63-9141的体外和体内特性，一种对耐甲氧西林葡萄球菌有活性的新型广谱头孢菌素。
Antimicrob Agents Chemother. 2001 Mar;45(3):825-36. doi: 10.1128/AAC.45.3.825-836.2001.
6
Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens.抗菌药物的药效学作为确定给药方案的基础。
Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S6-8. doi: 10.1007/BF02389870.
7
Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.美罗培南的抗生素后效应及抗生素后亚抑菌浓度效应研究。
J Antimicrob Chemother. 1993 Jun;31(6):881-92. doi: 10.1093/jac/31.6.881.
8
The post-antibiotic sub-MIC effect in vitro and in vivo.抗生素后亚抑菌浓度效应的体内外研究
J Antimicrob Chemother. 1993 May;31 Suppl D:159-66. doi: 10.1093/jac/31.suppl_d.159.
9
The post-antibiotic effect.抗生素后效应
J Antimicrob Chemother. 1993 Oct;32(4):519-37. doi: 10.1093/jac/32.4.519.
10
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.万古霉素、罗红霉素、司帕沙星和阿米卡星的抗生素后亚抑菌浓度效应。
Antimicrob Agents Chemother. 1992 Sep;36(9):1852-8. doi: 10.1128/AAC.36.9.1852.
Zotero 插件